智通财经网·2025-08-07 15:17Core Viewpoint - Spring Medical (01858) has announced an investment in the Nanchang Defu Phase IV Equity Investment Fund Partnership, focusing on the healthcare industry, which aligns with the company's main business [1] Investment Details - The company will invest 50 million RMB, representing 9.2105% of the fund's total shares [1] - The investment targets growth and mature enterprises/projects in the healthcare sector [1] Strategic Implications - This investment aligns with the company's strategic development direction and enhances its industrial layout [1] - Collaboration with partners is expected to leverage investment experience and resource advantages, promoting deep integration of industrial operations and capital management [1] - The initiative aims to create a virtuous cycle of collaborative development, enhancing the company's core competitiveness and overall profitability [1] - The goal is to achieve sustainable, safe, healthy, and stable high-quality development for the company [1]